Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis

Journal of Pathology

Volumn 188, Issue 1, 1999, Pages 63-68

  Pablos, Jose L ^a   Santiago, Begoña ^a   Galindo, Maria ^a   Carreira, Patricia E ^a   Ballestin, Claudio ^a   Gomez Reino, Juan J ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Apoptosis; Autoimmune diseases; Dermatomyositis; Keratinocytes; p53; Skin; Systemic lupus erythematosus; UV radiation

Indexed keywords

AUTOANTIGEN; CYCLINE; DNA FRAGMENT; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DNA DAMAGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLERODERMA; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; SOLAR RADIATION; ULTRAVIOLET B RADIATION;

ADULT; AGED; APOPTOSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DERMATOMYOSITIS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KERATINOCYTES; KI-67 ANTIGEN; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; SCLERODERMA, SYSTEMIC; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0032943731     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199905)188:1<63::AID-PATH303>3.0.CO;2-E     Document Type: Article

References (37)

1. Provost TT, Watson R. Pathogenesis of cutaneous manifestations of lupus erythematosus. In: Wallace DJ, Hahn D, eds. Dubois' Lupus Erythematosus. 4th edn. Philadelphia: Lea & Febiger, 1993: 279-301.
2. Bradley WG, Tandan R. Inflammatory diseases of muscle. In: Kelley WN, Harris ED, Jr Ruddy S, Sledge CB, eds. Textbook of Rheumatology. 3rd edn. Philadelphia: W B Saunders, 1989: 1263-1287.
3. Andrews BS, Schenk A, Barr R, Friou G, Mirick G, Ross P. Immunopathology of cutaneous human lupus erythematosus defined by murine monoclonal antibodies. J Am Acad Dermatol 1986; 15: 474-481.
4. Hausmann G, Herrero C, Cid MC, Casademont J, Lecha M, Mascaro JM. Immunopathologic study of skin lesions in dermatomyositis. J Am Acad Dermatol 1991; 25: 225-230.
5. Burnham TK, Neblett TR, Fine G. Application of fluorescent antibody technique to the investigation of lupus erythematosus and various dermatoses. J Invest Dermatol 1963; 41: 451-456.
6. Nesbitt LT Jr. Cutaneous immunofluorescence in dermatomyositis. Int J Dermatol 1980; 19: 270-278.
7. Janis JF, Winkelmann RK. Histopathology of the skin in dermatomyositis: a histopathologic study of 55 cases. Arch Dermatol 1968; 97: 640-650.
8. Cheong WK, Hughes RV, Norris PG, Hawk JL. Cutaneous photosensitivity in dermatomyositis. Br J Dermatol 1984; 131: 205-208.
9. Cohen MR, Isenberg A. Ultraviolet irradiation in systemic lupus erythematosus: friend or foe? Br J Rheumatol 1996; 35: 1002-1007.
10. Furukawa F, Kashihara-Sawami M, Lyons MB, Norris DA. Binding of antibodies to the extractable nuclear antigens of SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 1990; 94: 77-85.
11. Golan TD, Elkon KB, Gharavi AE, Krueger JG. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A radiation. J Clin Invest 1992; 90: 1067-1076.
12. Coates PJ, Save V, Ansari B, Hall PA. Demonstration of DNA damage/ repair in individual cells using in situ end labelling: association of p53 with sites of DNA damage. J Pathol 1995; 176: 19-26.
13. Schwarz A, Bhardwaj R, Aragane Y, et al. Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol 1995; 104: 922-927.
14. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-1330.
15. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995; 182: 1625-1634.
16. Casiano CA, Martin SJ, Green DR, Tan EM. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med 1996; 184: 765-770.
17. Casciola-Rosen L, Rosen A. Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus 1997; 6: 175-180.
18. Polakowska RR, Piacentini M, Bartlett R, Goldsmith LA, Haake AR. Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Dev Dynam 1994; 199: 176-188.
19. Maruoka Y, Harada H, Mitsuyasu T, et al. Keratinocytes become terminally differentiated in a process involving programmed cell death. Biochem Biophys Res Commun 1997; 238: 886-890.
20. Smith ML, Fornace AJ Jr. p53-mediated protective responses to UV radiation. Proc Natl Acad Sci U S A 1997; 94: 12 255-12 257.
21. Aboussekhra A, Wood RD. Detection of nucleotide excision repair incisions in human fibroblasts by immunostaining for PCNA. Exp Cell Res 1995; 221: 326-332.
22. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
23. Smith MD, Healy E, Thompson V, Morley A, Rees JL. Use of in situ detection of histone mRNA in the assessment of epidermal proliferation: comparison with the Ki-67 antigen and BrdU incorporation. Br J Dermatol 1995; 132: 359-366.
24. Radic MZ, Weigert M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 1994; 12: 487-520.
25. Korb LC, Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes. Complement deficiency and systemic lupus erythematosus revisited. J Immunol 1997; 158: 4525-4528.
26. Schur PH. Complement and systemic lupus erythematosus. In: Wallace DJ, Hahn D, eds. Dubois' Lupus Erythematosus. 4th edn. Philadelphia: Lea & Febiger, 1993: 120-127.
27. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-6965.
28. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994; 145: 1323-1336.
29. Bianchi L, Farrace MG, Nini G, Piacentini M. Abnormal Bcl-2 and 'Tissue' transglutaminase expression in psoriatic skin. J Invest Dermatol 1994; 103: 829-833.
30. Casciola-Rosen LA, Anhalt GJ, Rosen A. Scleroderma autoantigens are uniquely fragmented by metal-catalyszed oxidation reactions: implications for pathogenesis. J Exp Med 1997; 185: 71-79.
31. Lane DP. Cancer: p53 guardian of the genome. Nature 1992; 358: 15-16.
32. Hall PA, McKee PH, Menage HD, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993; 8: 203-207.
33. Jonason AS, Kunala S, Price GJ, et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci U S A 1996; 93: 14 025-14 029.
34. Ren ZP, Ponten F, Nister M, Ponten J. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis, Int J Cancer (Pred Oncol) 1996; 69: 174-179.
35. Harrison RF, Reynolds GM, Rowlands DC. Immunohistochemical evidence for the expression of proliferating cell nuclear antigen (PCNA) by non-proliferating hepatocytes adjacent to metastatic tumours and in inflammatory conditions. J Pathol 1993; 171: 115-122.
36. Brysk MM, Selvanayagam P, Arany I, Brysk H, Tyring SK, Rajaraman S. Induction of apoptotic nuclei by interferon-gamma and by predesquamin in cultured keratinocytes. J Interferon Cytokine Res 1995; 15: 1029-1035.
37. Schwarz A, Bhardwaj R, Aragane Y, et al. Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol 1995; 184: 922-927.